More Birth Control Pills Recalled for Potential Packaging Errors
On March 4, 2019, the FDA announced that Apotex—a Weston, Florida company—is voluntarily recalling four lots of Drospirenone and Ethinyl Estradiol birth control tablets. The…
FDA & Prescription Drugs
Family Found to Have Met Burden of Proof that Gardasil Caused Daughter’s Death
When their 21-year-old daughter died unexpectedly in 2008, shortly after receiving the Gardasil human papillomavirus (HPV) vaccine, the Tarsell family blamed the vaccine for the…
Lemtrada and Campath Linked with Serious Types of Stroke, FDA Warns
On November 29, 2018, the FDA warned about a rare but serious life-threatening risk of stroke and artery rupture in patients taking the multiple sclerosis…
Canada, Not U.S., Receives Official Warning About Tasigna Atherosclerosis
The FDA approved Tasigna (nilotinib) in 2007 for the treatment of chronic myelogenous leukemia (CML). A few years later, however, studies revealed a link between…
Janssen Recalls 3 Lots of Ortho Birth Control Pills for Misprinted Instructions
Janssen Pharmaceuticals recently announced the recall of one lot of Ortho-Novum 1/35 birth control pills and two lots of Ortho-Novum 7/7/7 birth control pills. The…
FDA Warns of a Rare Genital Infection Linked with Type 2 Diabetes Medications
Patients who are taking certain type 2 diabetes drugs need to be aware of a potential risk for a rare but serious genital infection. The…
Nevada Widow Files New Onglyza Lawsuit on Behalf of Her Deceased Husband
A Nevada widow recently filed a new Onglyza/Kombiglyze XR lawsuit in the U.S. District Court for the District of New Jersey on behalf of her…
Parties Ordered to Focus Only on General Causation Discovery in Onglyza MDL
The U.S. Judicial Panel on Multidistrict Litigation (JPML) ordered all federally-filed Onglyza lawsuits consolidated into the Eastern District of Kentucky back in February 2018. Since…
Texas Man Blames Onglyza for Heart Failure
A Texas man has brought new allegations against the makers of the type 2 diabetes drug Onglyza. In his Onglyza lawsuit, which was filed in…
New Valsartan Class Action Case Filed in New Jersey
A Texas man has filed a new class-action lawsuit against makers of the heart disease drug “valsartan.” He brings the claim on behalf of himself…